Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 713-720

  Cancello, G ^a   Maisonneuve, P ^a   Rotmensz, N ^a   Viale, G ^a,b   Mastropasqua, M G ^a   Pruneri, G ^a   Montagna, E ^a   Dellapasqua, S ^a   Iorfida, M ^a   Cardillo, A ^a   Veronesi, P ^a,b   Luini, A ^a   Intra, M ^a   Gentilini, O ^a   Scarano, E ^a   Goldhirsch, A ^a   Colleoni, M ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Immunohistochemistry; Prognosis; Subtypes; Tumour size

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 79958267860     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1465-7     Document Type: Article

References (21)

1. DA Berry KA Cronin SK Plevritis, et al. 2005 Effect of screening and adjuvant therapy on mortality from breast cancer N Engl J Med 353 1784 1792 16251534 10.1056/NEJMoa050518 1:CAS:528:DC%2BD2MXhtFKrtLbN (Pubitemid 41549890)
2. J Fracheboud SJ Otto JA van Dijck, et al. 2004 National Evaluation Team for Breast Cancer Screening (NETB): decreased rates of advanced breast cancer due to mammography screening in the Netherlands Br J Cancer 91 861 867 15292936 1:STN:280:DC%2BD2cvitF2rug%3D%3D (Pubitemid 39273776)
3. EO Hanrahan V Valero AM Gonzalez-Angulo GN Hortobagyi 2006 Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a, bN0M0): a review of the literature J Clin Oncol 24 2113 2122 16648513 10.1200/JCO.2005.02.8035 (Pubitemid 46628472)
4. CA Quiet DJ Ferguson RR Weichselbaum S Hellman 1995 Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up J Clin Oncol 13 1144 1151 7738620 1:STN:280:DyaK2M3ls12gtw%3D%3D
5. D Rosner W Lane 1993 Predicting recurrence in axillary-node negative breast cancer patients Breast Cancer Res Treat 25 127 139 8347845 10.1007/BF00662138 1:STN:280:DyaK3szltVaiuw%3D%3D (Pubitemid 23170612)
6. M Colleoni N Rotmensz G Peruzzotti, et al. 2004 Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies Ann Oncol 15 1633 1639 15520064 10.1093/annonc/ mdh434 1:STN:280:DC%2BD2crkslSksg%3D%3D (Pubitemid 39562603)
7. EO Hanrahan AM Gonzalez-Angulo SH Giordano, et al. 2007 Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma J Clin Oncol 25 4952 4960 17971593 10.1200/JCO.2006.08.0499 (Pubitemid 350220427)
8. AM Gonzalez-Angulo JK Litton KR Broglio, et al. 2009 High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller J Clin Oncol 27 5700 5706 19884543 10.1200/JCO.2009.23.2025
9. G Curigliano G Viale V Bagnardi, et al. 2009 Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer J Clin Oncol 27 5693 5699 19884553 10.1200/JCO.2009.22.0962
10. T Sorlie R Tibshirani J Parker, et al. 2003 Repeated observation of breast tumour subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528: DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
11. DS Oh MA Troester J Usary, et al. 2006 Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers J Clin Oncol 24 1656 1664 16505416 10.1200/JCO.2005.03.2755 1:CAS:528:DC%2BD28XksVKgtL0%3D (Pubitemid 46622136)
12. R Rouzier CM Perou WF Symmans, et al. 2005 Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 5678 5685 16115903 10.1158/1078-0432.CCR-04-2421 1:CAS:528:DC%2BD2MXos1Cjs7k%3D (Pubitemid 41170290)
13. CM Perou T Sorlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 10963602 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D
14. T Sorlie CM Perou R Tibshirani, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 11553815 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D (Pubitemid 32878711)
15. MC Cheang SK Chia D Voduc, et al. 2009 Ki67 index, HER2 status, and prognosis of patients with luminal b breast cancer J Natl Cancer Inst 101 736 750 19436038 10.1093/jnci/djp082 1:CAS:528:DC%2BD1MXmtlyit74%3D
16. J Hugh J Hanson MC Cheang, et al. 2009 Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial J Clin Oncol 27 1168 1176 19204205 10.1200/JCO.2008.18.1024 1:CAS:528:DC%2BD1MXktFKhs7Y%3D
17. G Cancello P Maisonneuve N Rotmensz, et al. 2010 Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer Ann Oncol 21 1974 1981 20332136 10.1093/annonc/mdq072 1:STN:280:DC%2BC3cfktFarsQ%3D%3D
18. Rosen PP, Oberman H (1993) Tumors of the mammary gland. Armed Forces Institute of Pathology, Washington, DC
19. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410 1757079 10.1111/j.1365-2559.1991.tb00229.x 1:STN:280:DyaK38%2FpvVSltw%3D%3D
20. G Viale MM Regan MG Mastropasqua, et al. 2008 Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer J Natl Cancer Inst 100 207 212 18230798 10.1093/jnci/djm289 1:CAS:528:DC%2BD1cXivFygs78%3D (Pubitemid 351480546)
21. JH Kwon YJ Kim KW Lee, et al. 2010 Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less BMC Cancer 10 557 20946688 10.1186/1471-2407-10-557